Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium in COPD with Concomitant Asthma
NCT00152984Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Dec 2004
- Primary completion
- Apr 2006
- Modality
- Small Molecules
- Countries
- 8
01
Overview
Phase 4, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) and asthma comparing Tiotropium with Placebo (2 arms). Primary endpoint: Area under the curve of change in FEV1 from baseline to 6 hours post dose. Started Dec 2004; status: completed.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)asthma
Beyond the preview
Go deeper on NCT00152984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00152984.